VIA Labs Announces Capital Lending to Subsidiary Huilianxinqiao Technology (Xiamen) Co., Ltd. in Accordance with Article 22, Paragraph 1, Subparagraph 3 of the Regulations Governing the Acquisition or Disposal of Assets by Public Companies

1. Date of occurrence of the event: 2026/05/06 2. Recipient of capital lending: (1) Company name: Huilianxinqiao Technology (Xiamen) Co., Ltd. (2) Relationship with the company lending capital to others: Directly holds over 50% of ordinary shares in the subsidiary. (3) Capital lending limit (in thousands of TWD): 573,441 (4) Original capital lending balance (in thousands of TWD): 0 (5) Amount of new capital lending (in thousands of TWD): 87,065 (6) Whether it is a capital lending authorized by the board of directors for multiple disbursements or revolving use to the same lending object: Yes (7) Capital lending balance as of the date of occurrence (in thousands of TWD): 87,065 (8) Reason for this new capital lending: Operational working capital needs 3. Collateral provided by the recipient of capital lending: (1) Content: None (2) Value (in thousands of TWD): 0 4. Latest financial report of the recipient of capital lending: (1) Capital (in thousands of TWD): 171,310 (2) Accumulated profit/loss amount (in thousands of TWD): -65,271 5. Interest calculation method: According to the agreed contractual interest rate 6. Repayment: (1) Conditions: According to the agreed contract (2) Date: According to the agreed contract 7. Capital lending balance as of the date of occurrence (in thousands of TWD): 87,065 8. Ratio of capital lending balance to the net worth of the public company's most recent financial report as of the date of occurrence: 3.04% 9. Source of the company's capital lent to others: Parent company 10. Other matters to be specified: 1. The latest financial report is the Q4 2025 financial report. 2. The exchange rate is based on Taiwan Bank's rates as of 2026.04.30: RMB to TWD 4.63, USD to TWD 31.66.